G

Gwinnett Research Institute | Buford, GA

Research site
(Unclaimed)
Location
2805 Hamilton Mill Road, Buford, Georgia, United States of America
Site insights

Top conditions

Gastroparesis (4 trials)

COVID-19 (2 trials)

Lung Cancer (1 trial)

Anemia (1 trial)

Alzheimer Disease (1 trial)

Top treatments

Relamorelin
Ferumoxytol
fezolinetant
Sargramostim
Belviq XR®
Ensovibep
Iron
Tiotropium
LY3002813
IONIS-AGT-LRx

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 14
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.Additional part...

Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo

This is a Phase 3, randomized, open-label, multicenter, study in male and female pediatric subjects (2 years to <18 years of age) with IDA, or felt b...

Enrolling
Iron Deficiency Anemia
Drug: Iron sucrose
Drug: ferumoxytol

Randomized, Placebo-controlled, Double-blind, Parallel-group, Multicenter, Phase 2a Study of the Efficacy and Safety of Oral AMT-101 in Subjects with...

Active, not recruiting
Ulcerative Colitis
Other: Placebo (oral)
Drug: AMT-101 (oral)

Trial sponsors

Allergan logo

Allergan (4 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems